QUANTUM BLOCKCHAIN TECHNOLOGIES PLC Logo

QUANTUM BLOCKCHAIN TECHNOLOGIES PLC

R&D firm using AI and quantum computing to create efficient technologies for Bitcoin mining.

QBT | IL

Overview

Corporate Details

ISIN(s):
GB00B50P5B53
LEI:
213800FC5DEC582CRZ89
Country:
United Kingdom
Address:
FIRST FLOOR, 1 CHANCERY LANE, WC2A 1LF LONDON
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Quantum Blockchain Technologies PLC is a research and development (R&D) company focused on creating disruptive technologies for Bitcoin mining. The company's approach integrates advanced artificial intelligence, quantum computing principles, cryptography, and functional optimisation with novel hardware designs, including Field-Programmable Gate Arrays (FPGAs) and Application-Specific Integrated Circuits (ASICs). Since commencing its intensive R&D program in 2021, the company's primary objective has been to develop proprietary systems and methods that provide a significant competitive advantage and enhance efficiency and performance in the Bitcoin mining sector.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-24 08:00
Interim Report
Quantum Blockchain Technologies Plc - Interim Results
English 270.3 KB
2025-07-01 12:11
Related Party Transaction
Quantum Blockchain Technologies Plc - REPO Rollover
English 66.7 KB
2025-06-24 08:00
Related Party Transaction
Quantum Blockchain Technologies Plc - Final Results
English 1.0 MB
2025-06-19 10:50
Regulatory News Service
Quantum Blockchain Technologies Plc - Business Update
English 23.3 KB
2025-06-03 08:00
Environmental & Social Information
Quantum Blockchain Technologies Plc - AI Oracle Video & Bitcoin 2025
English 12.1 KB
2025-05-21 08:00
Board/Management Information
Quantum Blockchain Technologies Plc - Directorate Change
English 17.0 KB
2025-05-19 13:31
Board/Management Information
Quantum Blockchain Technologies Plc - Passing of a Non-Exec Director
English 10.3 KB
2025-01-24 10:21
Related Party Transaction
Quantum Blockchain Technologies Plc - Rollover of REPO
English 64.7 KB
2025-01-23 08:00
Share Issue/Capital Change
Quantum Blockchain Technologies Plc - Placing
English 12.3 KB
2025-01-17 08:00
Environmental & Social Information
Quantum Blockchain Technologies Plc - Bitcoin Mining - Method C Update
English 26.9 KB
2025-01-15 08:00
Regulatory News Service
Quantum Blockchain Technologies Plc - AI Oracle Patent Application
English 14.3 KB
2024-12-11 08:00
Remuneration Information
Quantum Blockchain Technologies Plc - Amendment and Grant of Share Options
English 115.7 KB
2024-10-24 08:00
Share Issue/Capital Change
Quantum Blockchain Technologies Plc - Method C Update
English 29.4 KB
2024-10-02 08:00
Director's Dealing
Quantum Blockchain Technologies Plc - REPO Rollover
English 63.0 KB
2024-09-23 11:06
Interim Report
Quantum Blockchain Technologies Plc - Correction: Interim Results
English 290.5 KB

Automate Your Workflow. Get a real-time feed of all QUANTUM BLOCKCHAIN TECHNOLOGIES PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for QUANTUM BLOCKCHAIN TECHNOLOGIES PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Medivir Logo
Clinical-stage pharma firm developing tumor-directed therapies for high-need cancer patients.
Sweden MVIR
Sweden MBOLIC
Milton Essex Spolka Akcyjna Logo
Develops AI-powered, non-invasive systems for allergy diagnostics & personalized medicine.
Poland MTN
Molecular Partners AG Logo
Pioneering DARPin protein drugs for complex diseases in oncology and virology.
Switzerland MOLN
MorphoSys AG Logo
Biopharma company creating antibody therapies for oncology, with a focus on blood cancers.
Germany MOR
Mycodern Spolka Akcyjna Logo Poland MCD
N4 PHARMA PLC Logo
Developing a nanoparticle delivery system for advanced gene and vaccine therapies.
United Kingdom N4P
NextGen Biomed Ltd. Logo
R&D of biotech medical devices for diabetes care and topical skin treatments.
Israel NXGN
Nicox S.A. Logo
Developing innovative ophthalmology drugs for glaucoma and ocular hypertension.
France COX
ONCIMMUNE HOLDINGS PLC Logo
Antibody biomarker discovery platform for pharma and biotech partners in oncology and autoimmune disease.
United Kingdom ONC

Talk to a Data Expert

Have a question? We'll get back to you promptly.